Drug Abuse Testing Market to Grow at a CAGR of 5.7% to reach US$ 9,393.17 Million from 2019 to 2027

Drug Abuse Testing Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product (Rapid Testing Devices, Analyzers, and Consumables), Sample Type (Blood, Urine, Saliva, and Other Sample Types), and End User (Hospitals, Diagnostic Laboratories, and Forensic Laboratories)

Publication Month : Aug 2019

  • Report Code : TIPHE100001303
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 155
Inquire Before Buy




The drug abuse testing market is expected to grow from US$ 6,022.57 million in 2019 to US$ 9,393.17 million by 2027; it is estimated to record a CAGR of 5.7% from 2020 to 2027.

Drug abuse testing is used to perform to detect and evaluate overdose and drug intoxication. Cocaine, Marijuana, Opiates, LSD, Cannabinoids, Amphetamines, Alcohol, Diazepam, and Ketamine are commonly used drugs of abuse. The type of drug tests varies and depending on the type of drug being tested and the type of specimen being collected. The test specimens include such as hair, Urine, saliva (oral fluid) for the testing.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Drug Abuse Testing Market: Strategic Insights

Market Size Value inUS$ 6,022.57 Million in 2019
Market Size Value byUS$ 9,393.17 Million by 2027
Growth rateCAGR of 5.7% from 2020 to 2027
Forecast Period2020-2027
Base Year2019
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Drug Abuse Testing Market Insights

Laws and Regulations Related to Drug Abuse to Drives Growth of Drug Abuse Testing Market

Drug use in excess can have a wide range of short and long-term, direct, and indirect effects. Short-term effects can range from changes in restlessness, appetite, blood pressure, heart rate, stroke or heart attack, psychosis, overdose, and even death. These health-related effects can occur even after just one use of drugs. On the other hand, longer-term effects can include cancer, heart or lung disease, mental illness, hepatitis, HIV/AIDS, and others. The long-term drug use can also lead to an addiction that results in brain disorders such as, anxiety, paranoia, depression, aggression, hallucinations, and others. For instance, according to the National Institute of Drug use, approx. 43.4 million (17.9%) adults ages 18 and older experienced some form of mental illness in 2015, in which 8.1 million had both a substance use disorder and another mental illness.

The increasing use of illicit drugs is subjected to various regulations. The government conducts many acts for the law or regulation on drug abuse including SUPPORT Act, 21st Century Cures Act, Comprehensive Addiction and Recovery Act (CARA), Affordable Care Act (ACA), Tribal Law and Order Act (TLOA), Mental Health Parity and Addiction Equity Act, Americans with Disabilities Act (ADA), Sober Truth on Preventing (STOP) Underage Drinking Act, Garrett Lee Smith Memorial Act and Children’s Health Act.

Lucrative Regions for Drug Abuse Testing Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
According to the federal laws related to SAMHSA, SUPPORT Act promotes opioid recovery and treatment for Patients and Communities Act of 2018, was made a law to address the overdose of wide-ranging illicit drugs. Moreover, the 21st Century Cures Act was signed into law on December 2016. The act addresses many critical issues at the federal level, including accountability and leadership for mental or behavioral health disorders. The Cures Act also organized the Center for Behavioral Health Statistics and Quality (CBHSQ) that serves as the federal government’s lead agency for behavioral health statistics.

Moreover, the Comprehensive Addiction and Recovery Act (CARA) is imposed in 2016, that launched an evidence-based heroin and illicit drugs treatment and interventions program that further enforce prescription drug monitoring programs to help states monitor and track prescription drug alteration. The act also helps to expand prevention and educational efforts that mainly aimed at teens, parents, and aging populations. Hence, the increase in mental disorder cases due to use of the high doses of drugs is anticipated to help the market for drug-abuse testing in the forecast period.

Increasing Consumption of Illicit Drugs to Drives Growth of Drug Abuse Testing Market

Illicit drugs, including cocaine, amphetamines, heroin, hallucinogens are substances that can inhibit the central nervous system and also cause hallucinogenic effects. The National Household Survey on Drug Abuse (NSDUH) is a primary source of information on the patterns, prevalence, and consequences of alcohol, illegal drug use, and abuse in the general U.S.

 As per statistics provided by the National Survey on Drug Use and Health (NSDUH), approximately 19.7 million American adults (above 12 years of age) have faced a substance use disorder in 2017. According to SAMHSAM, marijuana is the most commonly used illicit drug in the United States. The laws regarding the use of marijuana have changed in several countries over the past decades. Marijuana classified as a Schedule I drug that is considered as having a high potential for drug abuse that has no currently accepted medical use in treatment in the United States yet. Almost 38% of the adult population in the U.S. have battled an illegal drug use disorder during the year 2017. Other than illicit drugs, the consumption of alcohol has observed among the individuals in the country. Nearly 74% of adults suffering from a substance use disorder in 2017 also struggled with an alcohol use disorder.

Across the United States, the increasing consumption of marijuana has a public health impact on local and state communities. As in results, people meeting the diagnostic standards for abuse or dependence on marijuana, which is the second leading factor for which people receive drug treatment (behind alcohol). As per the White House Office of National Drug Control Policy, the consequences of marijuana use have placed a substantial strain on the U.S. health care system. Therefore, owing to the factors mentioned above, the market for drug abuse testing is anticipated to grow significantly in the forecast period.

Product -Based Insights

Based on product, the drug abuse testing market is segmented rapid testing devices, analyzers, and consumables. In 2019, consumables segment held the largest share of the market. Moreover, the rapid testing devices segment is expected to grow at the fastest rate during the coming year.

Drug Abuse Testing market, by Component – 2018 and 2027

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Sample Type-Based Insights

Based on sample type, the drug abuse testing market is segmented into blood, urine, saliva, and other sample types. In 2019, urine segment held the largest share of the market. In addition, the segment is expected to grow at the fastest rate during the coming year.

End Users-Based Insights

Based on end user, the global drug abuse testing market is divided into hospitals, diagnostic laboratories, and forensic laboratories. In 2019, hospitals segment held the largest share of the market. Moreover, the segment is expected to grow at the fastest rate during the coming year.   

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the drug abuse testing market. A few recent key market developments are listed below:

  • In April 2018, Ortho Clinical Diagnostics announced the international distribution and copromotion agreement with Thermo Fisher Scientific, to provide 14 assays for use in monitoring therapeutic drugs, immunosuppressive drugs, and drugs of abuse.
  • In October 2017, Abbott announced that in a filing with the us securities and exchange commission, it has completed its acquisition of Alere, concluding a deal first announced in February 2016. redwood toxicology laboratory, which was initially a part of Alere was also acquired by Abbott as a part of this strategic acquisition.
  • In February 2018, Alfa Scientific Designs, Inc. received FDA approval for Instant-view-plus multi-drug of abuse urine test. The product has been approved for professional/over-the-counter (OTC) and CLIA-waived use and can be used for the identification of thirteen different drugs or drug metabolites.
  • In May 2017, Siemens launched new troponin test, the key biomarker used in heart attack diagnostics. Bioventix are also used for diagnosis or monitoring conditions like heart disease, cancer, fertility, thyroid function and drug abuse.  

Company Profiles   

  • Redwood Toxicology Laboratory (Abbott)
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc
  • OraSure Technologies, Inc.
  • UCP Biosciences
  • MEDACX Ltd.
  • Beckman Coulter, Inc. (Danaher)
  • Alcolizer Pty Ltd.
  • Wondfo
  • American Screening Corporation, Inc
  • Mercedes Medical
  • Alfa Scientific Designs, Inc.
  • Express Diagnostics Int'l, Inc.
  • Omega Laboratories, Inc.
  • Laboratorio Sodré
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Sample Type, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

  1. Redwood Toxicology Laboratory (Abbott)
  2. F. Hoffmann-La Roche Ltd.
  3. Thermo Fisher Scientific, Inc.
  4. OraSure Technologies, Inc.
  5. UCP Biosciences
  6. MEDACX Ltd.
  7. Beckman Coulter, Inc. (Danaher)
  8. Alcolizer Pty Ltd.
  9. Wondfo
  11. American Screening Corporation, Inc
  12. Mercedes Medical, Alfa Scientific Designs, Inc.
  13. Express Diagnostics Int'l, Inc.
  14. Omega Laboratories, Inc.
  15. Laboratorio Sodré.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports